Search Results - carl+wagner

11 Results Sort By:
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions.There are a...
Published: 4/14/2023   |   Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
Keywords(s):  
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Non-Cancer Therapeutics, Neurodegenerative Disease Technologies, Pharmaceuticals
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
Keywords(s): Simulation, Therapeutics
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
Keywords(s): Bio-Technology
Category(s): Life Science (All LS Techs), Cancer Therapeutics, Pharmaceuticals, Neurodegenerative Disease Technologies, Non-Cancer Therapeutics
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Pamela Marshall, Peter Jurutka, Carl Wagner
Keywords(s): Therapeutics
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
Keywords(s): Cancer, Diabetes, Parkinson's Disease
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
Keywords(s): Cancer, Diabetes, Parkinson's Disease
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
Keywords(s): Therapeutics
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
Keywords(s):  
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
Compounds to Modulate Retinoid X Receptors
The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
Published: 2/23/2023   |   Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
Keywords(s): Drug Screening
Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
Compositions and Extracts with Antiviral Activity
For the past half a century, alternative therapies to diseases have been increasingly sought in the US and globally. A 2002 study estimated 19 percent of adults used a botanical therapy to treat illnesses or conditions and that number seems to be rising. Isolating the active compounds of many botanicals offers novel treatment possibilities for a myriad...
Published: 2/23/2023   |   Inventor(s): Thomas Cahill, Jeffrey Langland, Bertram Jacobs, Carl Wagner, Guillermo Ruiz
Keywords(s):  
Category(s): Life Science (All LS Techs), Vaccines/Antimicrobials, Non-Cancer Therapeutics, Pharmaceuticals
1 2